Navigation Links
Simeprevir Administered Once Daily as Part of Combination Therapy Demonstrates Sustained Virologic Response in Treatment-Naive and Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Date:11/2/2013

                           
In a pooled analysis of the Phase 3 QUEST-1 and QUEST-2 studies, 80 percent of treatment-naive patients treated with simeprevir in combination with pegylated interferon and ribavirin achieved the primary endpoint of sustained virologic response 12 weeks after the end of treatment (SVR12) compared to 50 percent of patients treated with placebo plus pegylated interferon and ribavirin. The pooled analysis found that 61 percent of patients with the IL28B TT genotype, 60 percent of patients with a METAVIR score of F4 and 75 percent of patients with genotype 1a HCV treated with simeprevir combined with pegylated interferon and ribavirin achieved SVR12 compared to 21 percent, 34 percent and 47 percent of patients taking placebo plus pegylated interferon and ribavirin, respectively. Among patients with the genotype 1a Q80K polymorphism at baseline, 58 percent of patients treated with simeprevir combined with pegylated interferon and ribavirin achieved SVR12 compared to 52 percent of patients treated with placebo in combination with pegylated interferon and ribavirin, but the difference was not statistically significant.

Eight percent and 10 percent of patients treated with simeprevir combined with pegylated interferon and ribavirin experienced on-treatment failure and relapse, respectively, compared to 33 percent and 15 percent of patients taking placebo plus pegylated interferon and ribavirin, respectively. Three percent of patients treated with simeprevir discontinued treatment early due to an adverse event compared to two percent of patients treated with placebo.

Analysis from PROMISE Reinforces Efficacy of Simeprevir in Sub-Populations of Patients (Abstract 1092)                    
'/>"/>

SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
3. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
4. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
5. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
6. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
7. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
8. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
9. MCOs Shifting Control Over Office-Administered Products from Medical to Pharmacy Benefit, Particularly Affecting Rheumatoid Arthritis Therapies
10. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
11. Daiichi Sankyos Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE and Prevention of its Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. (OTC ... automated retailing, micro-stores, custom vending machines and kiosks, ... automated medicine dispensing systems, which can be used ... and marijuana dispensaries. AVT,s newly designed systems provide ... medicines and regulated products. "We are ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
(Date:7/21/2014)... July 21, 2014   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines ... & Drug Administration (FDA) has granted orphan drug ... oligonucleotide that binds to and inhibits the function ... treatment of Alport syndrome, a life-threatening genetic kidney ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5
... Recession-driven budget cuts by hospitals and governmental entities reduced sales ... throughout fiscal 2010.  The company managed to offset much of ...  Still, the company reported a loss for the year. ... Allied sales fell about $6 million, or more than 11.7 ...
... ATLANTA and NEW YORK, Aug. 30 Inc. ... 2230 on its fourth annual Inc. 5000 list, an ... list represents the most comprehensive look at the most ... Music website Pandora, convenience store chain 7-Eleven, Brooklyn Brewery, ...
Cached Medicine Technology:Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 2Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 3Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 4Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 5West Physics Consulting Lands on the 2010 Inc. 5000 List 2West Physics Consulting Lands on the 2010 Inc. 5000 List 3
(Date:7/22/2014)... 22, 2014 For the past nine ... have been working in tandem to help thousands of ... access to care, and help survivors connect to resources ... foundations expanded their partnership to include referrals from PAF ... with the other practical, emotional, and financial issues that ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Get ... the Immune Deficiency Foundation (IDF) to provide ... portal that will allow them to electronically track their ... manage their illnesses. It will also allow those patients ... to consent to have their data shared with ...
(Date:7/22/2014)... Atreo Services will be presenting its full range ... accessories in booth #1423 at the American Society for ... Chicago, Ill., Aug. 3-6. , Atreo will display its ... well as its selection of liners and inserts designed ... In addition, representatives will be available to talk about ...
(Date:7/22/2014)... 2014 Altec Products, Inc. , ... announced today their Gold Sponsorship of Sage Summit ... Bay Hotel and Casino in Las Vegas, Nevada. The ... thousands interested in taking advantage of the many opportunities ... business problems and educate themselves on the latest enterprise ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Dr. ... to announce the launch of a new website dedicated ... The website can be found at DrKamrava.com . ... provide patients with a knowledgeable and trustworthy source for ... they suffer from hemorrhoids, fissures, gallstones, colon cancer, hernias, ...
Breaking Medicine News(10 mins):Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3
... Texas, M. D. Anderson Cancer Center, John Mendelsohn, has been ... . This announcement was made in Paris, for his path ... Foundation which is located at the Tel Aviv University distributed ... million each to laureates chosen in areas where the contribution ...
... be the reason why isolated women are less vulnerable to falling ... ,The study is an eye-opener to the upcoming proof ... holds a clue to the reason why socially isolated men are ... studies have shown a connection between stress and immune function. But ...
... fall flat on its face, unless the government takes a leading ... local level work is going on in good measure, governments need ... area. The public Health Minister, Caroline Flint has confirmed the measures ... has sent the NHS expenditure sky rocketing almost ?1bn a year ...
... School of Public Health are one of the 14 ... Environmental Health Sciences// (NIEHS) to study the association between ... is a new study to control the rising obesity ... an individual’s body size. Working with various city departments, ...
... by Thomas Arcury, Ph.D., lead researcher, from Wake Forest University ... Carolina// widely use folk or home remedies, such as taking ... use is largely limited to home remedies, vitamins and minerals. ... more about what complementary and alternative medicine (CAM) therapies older ...
... to allegations that a perceived problem with the computer system ... schedule of thousands of babies and young children. ... initiative by the Government, to track the immunization schedule of ... that nearly 3,000 children would find themselves in the throes ...
Cached Medicine News:Health News:Women Portray Stronger Immune Response As Compared to Men, Study Suggests 2Health News:Inclination of North Carolina’s Elderly Population towards Home Remedie 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: